Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

In vitro study suggests acrylamide causes DNA damage

18.06.2003


Acrylamide, a possible human carcinogen that has been found in a variety of fried and starch-based foods, appears to exert its mutagenicity (the capacity to induce mutations) by forming DNA adducts and introducing genetic mutations, according to a study in the June 18 issue of the Journal of the National Cancer Institute. DNA adducts can interfere with the DNA replication process and lead to mutations and, in theory, to tumor formation.



Exposure to acrylamide has been shown to increase the incidence of a variety of cancers in rats and mice. Although no one knows how this process works, one theory is that acrylamide triggers mutagenesis by damaging DNA.

Ahmad Besaratinia, Ph.D., and Gerd P. Pfeifer, Ph.D., of the Beckman Research Institute of the City of Hope National Medical Center in Duarte, Calif., tested this hypothesis in mammalian cells in vitro by exposing mouse embryonic fibroblasts (connective tissue cells) that carried an artificially inserted gene known as a transgene to either acrylamide or a control, double-distilled water.


Cells treated with acrylamide had more DNA adduct formation at specific spots along the transgene than control-treated cells. Treatment of the cells with low (micromolar) concentrations of acrylamide was associated with a twofold increase in the number of mutations in the transgene compared with the control-treated cells. This mutation rate was similar to that of cells treated with the known carcinogen BPDE at considerably lower concentrations. However, treatment of the cells with higher concentrations of acrylamide (e.g., in the millimolar range) resulted in a mutation rate similar to that of untreated cells, possibly because cells die when exposed to such high concentrations of acrylamide.

The researchers also found that acrylamide exposure resulted in the formation of a spectrum of genetic mutations that were different from those mutations formed spontaneously. They point out, however, that the sites of acrylamide-induced DNA adducts did not match the pattern of acrylamide-induced mutations, suggesting that not all DNA adducts formed by acrylamide resulted in mutations.

The researchers note that the role of acrylamide in embryonic mouse fibroblasts may differ from its role in a grown animal. They acknowledge that their study was conducted on a transgene rather than a native gene and say that their findings cannot yet be applied to humans.

In an accompanying editorial, Fredrik Granath, Ph.D., of the Karolinska Institute in Stockholm, Sweden, and Margareta Törnqvist, Ph.D., of Stockholm University in Sweden, point out that the estimated average concentration of acrylamide in the blood is approximately 6 nanomolar, a concentration that is five times lower than the lowest concentration used in this study. "Studying effects at such low exposures is very difficult even in in vitro studies," they say. Considering the low statistical power in epidemiologic studies, they say that "clarification and improvement of the risk assessment of acrylamide will be obtained primarily from experimental studies."

They say that the estimated individual cancer risk from dietary acrylamide is quite small and they would not recommend changing nutritional guidelines. "However, the situation for vulnerable groups, e.g., pregnant women and children, should always be carefully considered," they write.


Contact: Greg Hughes, City of Hope National Medical Center, 626-359-8111 Ext. 65263; fax: 626-301-8462, ghughes@coh.org.

Editorial: Margareta Törnqvist, Stockholm University 46-8163-769, 46-703-736771 (cell), margareta.tornqvist@mk.su.se or Fredrik Granath (after June 18), Karolinska Institute, 46-8517-79182, fredrik.granath@mep.ki.se.

Besaratinia A, Pfeifer GP. Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst 2003;95:889–96.

Editorial: Granath F, Törnqvist M. Who knows whether acrylamide in food is hazardous to humans? J Natl Cancer Inst 2003;95:842–3.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Linda Wang | EurekAlert!
Further information:
http://jncicancerspectrum.oupjournals.org/

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-Ever 3D Printed Excavator Project Advances Large-Scale Additive Manufacturing R&D

Heavy construction machinery is the focus of Oak Ridge National Laboratory’s latest advance in additive manufacturing research. With industry partners and university students, ORNL researchers are designing and producing the world’s first 3D printed excavator, a prototype that will leverage large-scale AM technologies and explore the feasibility of printing with metal alloys.

Increasing the size and speed of metal-based 3D printing techniques, using low-cost alloys like steel and aluminum, could create new industrial applications...

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Paper – Panacea Green Infrastructure?

30.09.2016 | Event News

HLF: From an experiment to an establishment

29.09.2016 | Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

 
Latest News

First-Ever 3D Printed Excavator Project Advances Large-Scale Additive Manufacturing R&D

30.09.2016 | Materials Sciences

New Technique for Finding Weakness in Earth’s Crust

30.09.2016 | Earth Sciences

Cells migrate collectively by intermittent bursts of activity

30.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>